159 related articles for article (PubMed ID: 20517234)
41. Toxicity and survival results of a phase II study investigating the role of postoperative chemo-radioimmunotherapy for gastric adenocarcinoma.
Beşe NS; Büyükünal E; Ozgüroğlu M; Demir G; Yildirim A; Mandel NM; Demirelli F; Serdengeçti S; Ober A
Strahlenther Onkol; 2005 Oct; 181(10):652-9. PubMed ID: 16220404
[TBL] [Abstract][Full Text] [Related]
42. Laparoscopic total gastrectomy with D2 lymph node dissection for gastric cancer.
Shinohara T; Kanaya S; Taniguchi K; Fujita T; Yanaga K; Uyama I
Arch Surg; 2009 Dec; 144(12):1138-42. PubMed ID: 20026832
[TBL] [Abstract][Full Text] [Related]
43. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
[TBL] [Abstract][Full Text] [Related]
44. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.
Xu DZ; Geng QR; Long ZJ; Zhan YQ; Li W; Zhou ZW; Chen YB; Sun XW; Chen G; Liu Q
Ann Surg Oncol; 2009 Feb; 16(2):319-26. PubMed ID: 19050970
[TBL] [Abstract][Full Text] [Related]
45. Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery.
Laterza E; Giacopuzzi S; Minicozzi A; Saladino E; de Manzoni G
Ann Ital Chir; 2009; 80(2):101-6. PubMed ID: 19681290
[TBL] [Abstract][Full Text] [Related]
46. Aggressive D2 lymphadenectomy is required for accurate pathologic staging of gastric adenocarcinoma.
Smith BR; Stabile BE
Am Surg; 2006 Oct; 72(10):849-52. PubMed ID: 17058719
[TBL] [Abstract][Full Text] [Related]
47. [The role of D2 lymphadenectomy in the surgical treatment of gastric carcinoma].
Buris L; Halász L; Sasi SL; Czakó D
Magy Seb; 2002 Aug; 55(4):257-60. PubMed ID: 12236082
[TBL] [Abstract][Full Text] [Related]
48. [Comparative analysis of long-term results of combined and surgical treatment in gastric cancer].
Skoronad VIu; Berdov BA; Mardynskiĭ IuS; Titova LN
Vopr Onkol; 2007; 53(4):427-35. PubMed ID: 17969405
[TBL] [Abstract][Full Text] [Related]
49. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
50. Choice of the surgical treatment in early gastric cancer.
Custureri F; D'Orazi V; Peparini N; Gabatel R; Urciuoli P; Patrizi G; Redler A; Di Matteo G
Hepatogastroenterology; 2004; 51(58):1210-4. PubMed ID: 15239281
[TBL] [Abstract][Full Text] [Related]
51. Indications for pancreaticosplenectomy in advanced gastric cancer.
Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
[TBL] [Abstract][Full Text] [Related]
52. Lymphadenectomy for gastric adenocarcinoma: should west meet east?
Yoon SS; Yang HK
Oncologist; 2009 Sep; 14(9):871-82. PubMed ID: 19738001
[TBL] [Abstract][Full Text] [Related]
53. Surgical outcome of node-positive early gastric cancer with particular reference to nodal status.
Kikuchi S; Sato M; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Kakita A
Anticancer Res; 2000; 20(5C):3695-700. PubMed ID: 11268441
[TBL] [Abstract][Full Text] [Related]
54. [Postoperative radio-chemotherapy in locally advanced gastric cancer].
Garrido M; Bustos M; Orellana E; Madrid J; Galindo H; Sánchez C; Pimentel F; Guzmán S; Ibáñez L; Butte JM; Alvarez M; Besa P
Rev Med Chil; 2008 Jul; 136(7):844-50. PubMed ID: 18949159
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.
Ojima H; Araki K; Kato T; Okamura K; Manda R; Hirayama I; Hosouchi Y; Nishida Y; Kuwano H
Anticancer Res; 2006; 26(2B):1385-90. PubMed ID: 16619548
[TBL] [Abstract][Full Text] [Related]
56. [Intraoperative radiotherapy in gastric adenocarcinomas. Apropos of 45 cases].
Gilly FN; Gérard JP; Braillon G; Romestaing P; Sentenac I; Rocher F; Brachet A; Rebaudet H; Vignal J; Bérard P
Ann Chir; 1993; 47(3):234-9. PubMed ID: 8333718
[TBL] [Abstract][Full Text] [Related]
57. [Extended D3 lymphadenectomy in surgical treatment of stomach cancer].
Khvastunov RA; Shereshkov AIu; Shirokov OV; Ivanov AI; Mudryĭ AIu; Danilov SP
Khirurgiia (Mosk); 2007; (12):34-8. PubMed ID: 18163112
[TBL] [Abstract][Full Text] [Related]
58. [Immediate results of surgical treatment of stomach cancer].
Arutiunian GA; Kryzhanovskiĭ AI; Selin SM; Arutiunian VA; Polikarpov SA
Khirurgiia (Mosk); 2003; (7):55-8. PubMed ID: 12926341
[TBL] [Abstract][Full Text] [Related]
59. Full robotic gastrectomy with extended (D2) lymphadenectomy for gastric cancer: surgical technique and preliminary results.
D'Annibale A; Pende V; Pernazza G; Monsellato I; Mazzocchi P; Lucandri G; Morpurgo E; Contardo T; Sovernigo G
J Surg Res; 2011 Apr; 166(2):e113-20. PubMed ID: 21227455
[TBL] [Abstract][Full Text] [Related]
60. [The influence of lymphadenectomy on the results of the gastric cancer treatment].
Skoropad VIu; Berdov BA
Khirurgiia (Mosk); 2013; (1):25-33. PubMed ID: 23503346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
